Skip to main content


Scientific Name(s): Andrographis paniculata (Burm.f.) Wall. ex Nees
Common Name(s): Alui, Bhui-neem, Bhunimba, Chuan Xin Lian, Chuanxinlian, Creat, Green chireta, Kalmegh, Kalmegha, King of bitters, Kirayat, Mahatita, Nemone chinensi, Sam biloto, Yavatikta

Medically reviewed by Last updated on Dec 1, 2022.

Clinical Overview


Traditionally, andrographis has been used as an immunostimulant and antipyretic. Andrographis extract has been clinically studied for potential anti-inflammatory, antiviral, and immunostimulant activities, as well as for a potential role in osteoarthritis and hypertriglyceridemia. However, limited quality clinical studies exist to recommend use for any indication.


Limited quality clinical studies exist to provide dosing recommendations. See specific indications in Uses and Pharmacology section.


Contraindications have not been identified.


Avoid use. Adverse effects, including abortifacient effects, have been documented.


None well documented.

Adverse Reactions

In a clinical trial, headache, fatigue, rash, bitter/metallic taste, diarrhea, pruritus, and decreased sex drive were reported with andrographis 10 mg/kg body weight. One participant who was HIV positive experienced an anaphylactic reaction.


No data.

Scientific Family

  • Acanthaceae (Acanthus)


A. paniculata is an erect annual herb native to India, China, and Southeast Asia and widely cultivated in Asia. The plant grows 30 to 110 cm in height. The square stem has wings on the angles of new growth and is enlarged at the nodes. The seeds are yellowish-brown, and small white flowers with rose-purple spots are borne on a spreading panicle. All plant parts have an extremely bitter taste. The aerial portion of the plant is harvested in the fall. The genetic variability of the species has been examined.(Hossain 2014, Hu 2017, Padmesh 1999, USDA 2022)


A. paniculata has been used for centuries in India, China, Thailand, and other Asian countries and is present in 26 polyherbal formulations in the Ayurvedic traditional health system. A. paniculata is listed in the Pharmacopoeia of the People's Republic of China (1992 edition) as a cold property herb used to rid the body of fever and dispel toxins. An immunostimulant preparation known as Kan Jang (fixed herbal combination containing standardized A. paniculata [N.] SHA-10 extract) has been used in Scandinavian countries. A. paniculata is also manufactured and marketed in the United States.(Gabrielian 2002, Hossain 2014, Kumar 2004, Panossian 2002)


The diterpene lactone andrographolide was first isolated as a major constituent of A. paniculata(Boorsma 1996) and later characterized as a lactone.(Gorter 1914, Schwyzer 1951) Its full structure was determined in the 1960s,(Cava 1962, Chan 1963) and x-ray crystallography later confirmed the structure.(Smith 1982) Several related minor diterpenes and their glycosides have since been identified.(Balmain 1973, Fujita 1984, Jantan 1994, Kleipool 1952, Kumar 2004, Reddy 2005, Smith 2006, Weiming 1982) Methods of analysis, including high-pressure liquid chromatography and nuclear magnetic resonance,(Medforth 1990) have been published. A method for rapid isolation of andrographolide is also available.(Rajani 2000) When callus cultures of the plant were investigated, andrographolide and the other diterpenes were not produced. Instead, the sesquiterpenes paniculides A through C were found.(Allison 1968) Other constituents of the plant include various flavones.(Hossain 2014, Kuroyanagi 1987, Reddy 2005, Sareer 2014)

Uses and Pharmacology

Alcohol use disorder

Animal data

Both the extract of A. paniculata and andrographolide reduced alcohol-seeking behavior in rats genetically prone to prefer alcohol (P<0.001 for each). The extract also reduced cue-induced but not yohimbine-induced alcohol seeking.(Stopponi 2021)

Anti-inflammatory effects

Animal data

In several cellular systems, andrographolide has demonstrated anti-inflammatory effects, including prevention of phorbol ester–induced reactive oxygen species and N-formyl-methionyl-leucyl-phenylalanine–induced adhesion in rat neutrophils,(Hidalgo 2005, Shen 2000) inhibition of tumor necrosis factor–induced upregulation of intercellular adhesion molecule expression, monocyte adhesion,(Habtemariam 1998)) and activation of protein kinase pathways.(Chen 2004) In a rat model of gout, both andrographolide and an alcoholic extract of andrographis demonstrated extensive reductions in many inflammatory cytokines, as well as reduced uric acid levels.(Rahmi 2022)

Clinical data

Two randomized, double-blind clinical studies in patients with ulcerative colitis (N=120 and N=224) suggest extracts of andrographis may be as effective as mesalamine. Dosages of 1,200 mg or 1,800 mg of A. paniculata extract daily (in 3 divided doses) for 8 weeks were used in the studies.(Sandborn 2013, Tang 2011)

In 60 patients with rheumatoid arthritis, andrographolides 30 mg taken 3 times daily over 14 weeks resulted in improved rheumatoid symptoms of swelling and tenderness; reductions in rheumatoid factor and other indices were also associated with treatment compared with placebo.(Burgos 2009)

A clinical study assessing the effects of twice-daily A. paniculata 170 mg on relapse rate and fatigue in 25 patients with multiple sclerosis reported reductions in fatigue.(Bertoglio 2016)

Antimicrobial and antiviral effects

Animal and in vitro data

Extracts of andrographis and andrographolide derivatives have shown modest activity in vitro against HIV.(Basak 1999, Chang 1988, Otake 1995, Reddy 2005, Yao 1992) Cell culture studies of andrographolide have also demonstrated effects against 2 viruses in the Flaviviridae family: dengue virus (serotypes 2 and 4)(Panraksa 2017) and Japanese encephalitis virus.(Bhosale 2021) The ethanolic extract of A. paniculata (7.9% andrographolide) and its major constituent andrographolide demonstrated inhibitory activity against SARS-CoV-2 virus replication in human lung epithelial cells in a dose-dependent manner in vitro. Respective IC50 values for A. paniculata and andrographolide were 0.036 mcg/mL and 0.034 mcM using plaque assays that measure infectivity of virions released from the host cell. In contrast, IC50 values were higher using assay methods that require expression of specific antibodies. This difference demonstrated that A. paniculata and andrographolide interfere more with the production of infectious viral progeny than the early phase of viral replication. The A. paniculata extract demonstrated no cytotoxicity in cell lines of major organs (ie, lung, liver, brain, kidney, intestines); however, andrographolide demonstrated a narrow safety index in brain cells. Low bioavailability of andrographolide was also noted as a potential limitation for clinical applications.(Sa-Ngiamsuntorn 2021)

Antimalarial activity has also been noted during screening of andrographis extracts.(Misra 1992, Najib 1999, Siti Najila 2002)

The extract of A. paniculata blocked Escherichia coli enterotoxin–induced secretion in rabbit and guinea pig models of diarrhea.(Gupta 1993) Andrographolide and 3 other related diterpenes were responsible for this action.(Gupta 1990) Results from other in vitro experiments evaluating the action of andrographolide and A. paniculata leaf extracts on E. coli are conflicting.(Singha 2003, Voravuthikunchai 2006)

Clinical data

A phase 1 study of andrographolide use in patients who were HIV positive showed no effect on viral replication after 6 weeks, despite increased CD4+ counts.(Calabrese 2000)

Clinical trials have demonstrated beneficial results regarding respiratory infections, but methodology used is often of poor quality.(Gabrielian 2002, Hancke 1995, Spasov 2004) A clinical study evaluated the effect of A. paniculata extract 200 mg/day for 5 days on 9 self-evaluated symptoms (cough, expectoration, nasal discharge, headache, fever, sore throat, earache, malaise/fatigue, and sleep disturbance) in uncomplicated upper respiratory tract infection (N=223), with results favoring the study preparation over placebo.(Saxena 2010) A retrospective study of patients hospitalized with COVID-19 in Thailand found no difference in pneumonia rates for treatment with andrographolide 180 mg for 5 days compared with conventional therapy.(Tanwettiyanont 2022)


Animal and in vitro data

In animal and in vitro experiments using human cancer cell lines to investigate the potential anticancer effects of A. paniculata, andrographolide was responsible for the observed beneficial effects rather than other diterpenes.(Kumar 2004, Mishra 2015, Nanduri 2004, Zhou 2006) Various mechanisms of action have been proposed, including enhancement of chemokine activity, inhibition of tumor-specific angiogenesis affecting cell cycle progression, and induction of apoptosis.(Ji 2005, Kumar 2004, Nanduri 2004, Sheeja 2007, Zhou 2006) Cancer cell lines investigated included prostate, breast, cervical, colon, hepatoma, melanoma, and lymphocytic leukemia. Researchers are focusing on synthesizing compounds based on andrographolide to improve selectivity and potency.(Jada 2006, Nanduri 2004)

Caution is recommended due to the potential for andrographolide-enhanced SDF-1-chemokine activity, which might induce tumor cell metastasis.(Ji 2005) A. paniculata extract has also induced cell differentiation in mouse myeloid leukemia cells.(Matsuda 1994)

CNS effects

Animal and experimental data

In silico simulations identified 3 compounds from A. paniculata with high binding affinity for 3 beta-amyloid target enzymes (ie, human acetylcholinesterase [AChE], butylcholinesterase [BChE], and beta-secretase-1 [BACE-1]) and, therefore, might serve as potential anti-amyloid/Alzheimer agents. Subsequent in vitro studies demonstrated one of the compounds (3,4-di-o-caffeoylquinic acid) to have better mean IC50 values against both AChE (2.14 mcM) and BChE (1.44 mcM) than the positive control physostigmine (3.39 mcM and 2.88 mcM, respectively). Similar cholinesterase inhibition was observed with the second compound (7-o-methylwogonin), which had mean IC50 values for AChE (2.46 mcM) and BChE (1.46 mcM) that were also lower than physostigmine, while the third compound (apigenin) demonstrated better inhibition of BChE (1.97 mcM) than AChE (3.42 mcM). Only 7-o-methylwogonin was observed to have comparable inhibition of BACE-1 as the positive control (quercetin); both demonstrated an IC50 of 2.91 mcM, while the other 2 compounds were slightly less active against BACE-1.(Panche 2019) These effects were supported by a subsequent rat dementia (amnestic) model in which an aqueous extract of A. paniculata leaves significantly improved memory and cognitive function (P<0.05) compared with controls. Pretreatment with the extract prevented the increases in AChE, BChE, and MAO in the hippocampus induced by scopolamine.(Adedayo 2021)


Animal data

Male rats that consumed an A. paniculata leaf decoction daily for 8 weeks exhibited dose-dependent decreases in sperm counts, motility, and viability compared with controls. Results were marginal except in the high-dose group (1,000 mg/kg), for which decreases were significant compared with control (P<0.05). The high-dose group demonstrated normal seminiferous tubules with complete maturation and presence of spermatozoa; however, fibrosis in the lumen and degenerated germ cells were observed. Significant reductions in Leydig cell mass (steroidogenesis), mean seminiferous tubular diameter, and spermatogenic index (spermatogenesis) were also evident compared with controls. The mechanism appeared to be related to dose-dependent reductions in testosterone and increases in follicle-stimulating hormone (FSH) and luteinizing hormone (LH), as well as improved redox and inflammatory processes.(Ogundola 2021)

Hepatoprotective effects

Animal data

The extract of A. paniculata has demonstrated hepatoprotective activity in animal studies.(Kapil 1993, Trivedi 2000, Visen 1993) Hepatic drug-metabolizing enzymes were elevated in one animal experiment.(Visen 1993) However, it should be noted that in one clinical trial evaluating use of andrographolide, elevated liver enzymes were reported.(Calabrese 2000)


Clinical data

In a clinical study of patients with modest hypertriglyceridemia (N=60), administration of A. paniculata extract (andrographolide) 120 mg/day improved serum triglyceride levels.(Phunikhom 2015)

Hypoglycemic effects

Animal data

Extracts of andrographis have demonstrated hypoglycemic action in rats with streptozotocin- and alloxan-induced diabetes, which supports traditional use of the plant in diabetes.(Husen 2004, Reddy 2005, Zhang 2000)

Hypotensive effects

Clinical data

Two older trials explored the possible hypotensive effects of andrographolide/andrographis, but further investigation is needed.(Reyes 2006, Zhang 1999)

Immunostimulant activity

Stimulation of the production of key cytokines and immune activation markers has been investigated as a potential mechanism of andrographolide immunomodulation.(Ji 2005, Ko 2006, Panossian 2002)

Animal data and in vitro data

In one study, both antigen-specific and antigen-nonspecific immune responses in mice were stimulated by andrographolide and an ethanolic extract; the extract was more potent than andrographolide, suggesting that other constituents of the extract were also immunostimulants.(Puri 1993) Inhibition of passive cutaneous anaphylaxis and mast cell stabilization was observed in studies of the purified diterpenes in rats.(Gupta 1998)

Clinical data

In 30 healthy adults enrolled in an open-label, single-arm pilot study, levels of interferon (IFN)-gamma and interleukin 4 (IL-4) were significantly increased while IL-2 was significantly decreased after 30 days of A. paniculata (standardized to at least 33% diterpene lactones and 30% andrographolide) 100 mg twice daily. The primary outcome of change in natural killer cells was not found to be evident; however, a trend for increased total lymphocytes, CD3+ T-cells, and CD3+CD4+ T-helper cells was noted. In the subgroup of patients with baseline lymphocyte counts that ranged from 1,000 to 3,000 cells/mm3 (n=21), the changes in lymphocyte counts were statistically significant compared with baseline. Andrographis was well tolerated with no adverse events reported.(Rajanna 2021)

Insecticidal activity

Experimental data

Repellency activity of an ethanolic extract of A. paniculata leaves was investigated against 5 important mosquito species that are human pathogen vectors in Thailand. Significant activity was observed for most mosquitoes, with high repellency demonstrated against Aedes aegypti (dengue) and moderate activity observed against Anopheles dirus (malaria) and Culex quinquefasciatus (human lymphatic filariasis). Andrographolide and 14-deoxyandrographolide were determined to be the main active compounds.(Sukkanon 2020)


Clinical data

In a double-blind, randomized, controlled study of Asian patients with osteoarthritis of the knee (N=103), twice-daily administration of 150 or 300 mg of a standardized extract of A. paniculata (50% andrographolide) for 3 months significantly reduced pain scores, stiffness, physical function, and total Western Ontario and McMaster Universities Osteoarthritis (WOMAC) score compared with placebo (P<0.0001 for each). Additionally, fatigue and quality of life were significantly improved in the A. paniculata group compared with placebo (P=0.0001 for each).(Hancke 2019)

Renal toxicity

Animal data

Nephroprotective effects of A. paniculata have been demonstrated in animal models of diabetic nephropathy and drug-induced nephrotoxicity.(Hidayat 2021, Sharma 2022) A. paniculata extract not only ameliorated kidney hypertrophy in a diabetic rat model but also significantly improved body weight, fasting blood glucose, urine creatinine, albumin, triglycerides, cholesterol, and advanced glycation end products.(Hidayat 2021) Meanwhile, nephrotoxicity in rats induced by antitubercular drugs was mitigated with a high dose of A. paniculata leaf extract (300 mg/kg), with serum renal function markers (urea, creatinine, uric acid) restored towards normal values.(Sharma 2022)


Limited quality clinical studies exist to provide dosing recommendations.


One small study evaluated the immunostimulant effects of A. paniculata (standardized to at least 33% diterpene lactones and 30% andrographolide) 100 mg twice daily for 30 days.(Rajanna 2021)


Twice-daily administration of 150 or 300 mg of a standardized extract of A. paniculata (50% andrographolide) for 3 months was evaluated in patients with osteoarthritis of the knee.(Hancke 2019)

Respiratory tract infection

A clinical study evaluated the effect of A. paniculata extract 200 mg/day for 5 days on symptoms of uncomplicated upper respiratory tract infection.(Saxena 2010)

Ulcerative colitis

A. paniculata extract dosages of 1,200 or 1,800 mg daily (in 3 divided doses) for 8 weeks were used in studies of ulcerative colitis.(Sandborn 2013, Tang 2011)

Pregnancy / Lactation

Avoid use. Adverse effects, including abortifacient effects, have been documented.(McGuffin 1997)


None well documented.

Adverse Reactions

Research reveals few adverse reactions reported with use of A. paniculata. However, adverse reactions (eg, headache, fatigue, rash, bitter/metallic taste, diarrhea, pruritus, decreased sex drive) during a phase 1 study of andrographolide in patients who were HIV positive and healthy volunteers required interruption of the trial. One participant who was HIV positive experienced an anaphylactic reaction. Adverse reactions became apparent at an andrographolide dose of 10 mg/kg body weight.(Calabrese 2000) In the same trial, elevated liver enzymes were experienced by many subjects. Two cases of urticaria were reported in other trials.(Poolsup 2004) A meta-analysis of trials of andrographis and andrographolide derivatives found that adverse effects, including death, were more frequent with the derivatives, while adverse reactions with andrographis were generally mild to moderate.(Shang 2022)


Toxicology studies are limited, but andrographis does not appear to be acutely toxic. Acute lethal doses (median lethal dose) in mice are reported to be more than 40 g/kg for andrographolide.(Calabrese 2000)

Ames, chromosome aberration, and micronucleus in vitro tests on a standardized extract of A. paniculata demonstrated no evidence of mutations or clastogenicity, and no evidence of acute toxicity was observed in the female rats studied.(Chandrasekaran 2009)

Male reproductive toxicity studies have been conducted with andrographis. A subchronic 60-day study in male rats showed no changes in testicular weight, histology, or testosterone levels.(Burgos 1997) However, studies in rats given purified andrographolide for 48 days showed decreases in sperm counts and motility that were linked to disruption of spermatogenesis.(Akbarsha 2000, Hossain 2014)



This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

Adedayo BC, Jesubowale OS, Adebayo AA, Oboh G. Effect of Andrographis paniculata leaves extract on neurobehavioral and biochemical indices in scopolamine-induced amnesic rats. J Food Biochem. 2021;45(3):e13280. doi:10.1111/jfbc.1328032441354
Akbarsha MA, Murugaian P. Aspects of the male reproductive toxicity/male antifertility property of andrographolide in albino rats: effect on the testis and the cauda epididymidal spermatozoa. Phytother Res. 2000;14(6):432-435. doi:10.1002/1099-1573(200009)14:6<432::aid-ptr622>;2-i10960897
Allison AJ, Butcher DN, Connolly JD, Overton KH. Paniculides A, B, and C, bisabolenoid lactones from tissue cultures of Andrographis paniculata. Chem Commun. 1968;(23):1493.
Amaryan G, Astvatsatryan V, Gabrielyan E, Panossian A, Panosyan V, Wikman G. Double-blind, placebo-controlled, randomized, pilot clinical trial of lmmunoGuard—a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever. Phytomedicine. 2003;10(4):271-285. doi:10.1078/09447110332200476712809357
Andrographis paniculate (Burm. F.) Wall. Ex Nees. USDA, NRCS. 2022. The PLANTS Database (, 27 October 2022). National Plant Data Team, Greensboro, NC 27401-4901 USA.
Balmain A, Connolly JD. Minor diterpenoid constituents of Andrographis paniculata Nees. J Chem Soc Perkin. 1973;1:1247-1251.
Basak A, Cooper S, Roberge AG, Banik UK, Chrétien M, Seidah NG. Inhibition of proprotein convertases-1, -7 and furin by diterpines of Andrographis paniculata and their succinoyl esters. Biochem J. 1999;338(pt 1):107-113.9931305
Bertoglio JC, Baumgartner M, Palma R, et al. Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study. BMC Neurol. 2016;16:77. doi:10.1186/s12883-016-0595-227215274
Bhosale S, Kumar A. Screening of phytoconstituents of Andrographis paniculata against various targets of Japanese encephalitis virus: an in-silico and in-vitro target-based approach. Curr Res Pharmacol Drug Discov. 2021;2:100043. doi:10.1016/j.crphar.2021.10004334909671
Boorsma W. Meds Lands Plant. 1996;18:63-66.
Burgos RA, Caballero EE, Sánchez NS, Schroeder RA, Wikman GK, Hancke JL. Testicular toxicity assessment of Andrographis paniculata dried extract in rats. J Ethnopharmacol. 1997;58(3):219-224. doi:10.1016/s0378-8741(97)00099-89421258
Burgos RA, Hancke JL, Bertoglio JC, et al. Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial. Clin Rheumatol. 2009;28(8):931-946. doi:10.1007/s10067-009-1180-519408036
Cáceres DD, Hancke JL, Burgos RA, Sandberg F, Wikman GK. Use of visual analogue scale measurements (VAS) to asses the effectiveness of standardized Andrographis paniculata extract SHA-l0 in reducing the symptoms of common cold. A randomized double blind-placebo study. Phytomedicine. 1999;6(4):217-223. doi:10.1016/S0944-7113(99)80012-910589439
Calabrese C, Berman SH, Babish JG, et al. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res. 2000;14(5):333-338. doi:10.1002/1099-1573(200008)14:5<333::aid-ptr584>;2-d10925397
Cava MP, et al. The structure of Andrographolide. Tetrahedron. 1962;18:397-403.
Chan W, et al. The stereochemistry of andrographolide. Chem Ind. 1963;495.
Chandrasekaran CV, Thiyagarajan P, Sundarajan K, et al. Evaluation of the genotoxic potential and acute oral toxicity of standardized extract of Andrographis paniculata (KalmCold). Food Chem Toxicol. 2009;47(8):1892-1902. doi:10.1016/j.fct.2009.05.00619447157
Chang RS, Yeung HW. Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs. Antiviral Res. 1988;9(3):163-175. doi:10.1016/0166-3542(88)90001-02840849
Chen JH, Hsiao G, Lee AR, Wu CC, Yen MH. Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway. Biochem Pharmacol. 2004;67(7):1337-1345. doi:10.1016/j.bcp.2003.12.01515013849
Fujita T, Fujitani R, Takeda Y, et al. On the diterpenoids of Andrographis paniculata: x-ray crystallographic analysis of andrographolide and structure determination of new minor diterpenoids. Chem Pharm Bull. 1984;32(6):2117-2125.
Gabrielian ES, Shukarian AK, Goukasova GI, et al. A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine. 2002;9(7):589-597. doi:10.1078/09447110232161639112487322
Gorter M. The bitter constituent of Andrographis paniculata. Rec Tray Chim. 1914;33:239-243.
Gupta P, Tandon JS, Patnaik GK. Antiallergic activity of andrographolides isolated from Andrographis paniculata (Burm. f.) Wall. Pharm Biol. 1998;36(1):72-74.
Gupta S, Choudhry MA, Yadava JNS, Srivastava V, Tandon JS. Antidiarrhoeal activity of diterpenes of Andrographis paniculata (Kal-Megh) against Escherichia coli enterotoxin in in vivo models. J Crude Drug Res. 1990;28(4):273-283.
Gupta S, Yadava NS, Tandon JS. Antisecretory (antidiarrheal) activity of Indian medicinal plants against Escherichia coli enterotoxin-induced secretion in rabbit and guinea pig ileal loop models. Int J Pharmacognosy. 1993;31(3):198-204.
Habtemariam S. Andrographolide inhibits the tumor necrosis factor-a-induced upregulation of ICAM-1 expression and endothelial-monocyte adhesion. Phytother Res. 1998;12:37-40.
Hancke J, Burgos R, Caceres D, Wikman G. A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvement in the recovery from common colds. Phytother Res. 1995;9(8):559-562.
Hancke JL, Srivastav S, Cáceres DD, Burgos RA. A double-blind, randomized, placebo-controlled study to assess the efficacy of Andrographis paniculata standardized extract (ParActin) on pain reduction in subjects with knee osteoarthritis. Phytother Res. 2019;33(5):1469-1479. doi:10.1002/ptr.633930968986
Hidalgo MA, Romero A, Figueroa J, et al. Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells. Br J Pharmacol. 2005;144(5):680-686. doi:10.1038/sj.bjp.070610515678086
Hidayat R, Wulandari P. Effects of Andrographis paniculata (Burm. F.) extract on diabetic nephropathy in rats. Rep Biochem Mol Biol. 2021;10(3):445-454. doi:10.52547/rbmb.10.3.44534981022
Hossain MS, Urbi Z, Sule A, Hafizur Rahman KM. Andrographis paniculata (Burm. f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology. ScientificWorldJournal. 2014;2014:274905. doi:10.1155/2014/27490525950015
Hu XY, Wu RH, Logue M, et al. Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: a systematic review and meta-analysis. PLoS One. 2017;12(8):e0181780. doi:10.1371/journal.pone.018178028783743
Husen R, Pihie AH, Nallappan M. Screening for antihyperglycaemic activity in several local herbs of Malaysia. J Ethnopharmacol. 2004;95(2-3):205-208. doi:10.1016/j.jep.2004.07.00415507337
Jada SR, Hamzah AS, Lajis NH, Saad MS, Stevens MF, Stanslas J. Semisynthesis and cytotoxic activities of andrographolide analogues. J Enzyme Inhib Med Chem. 2006;21(2):145-155. doi:10.1080/1475636050049998816789428
Jantan I, Waterman PG. Ent-14beta-hydroxy-8(17),12-labdadien-16,15-olide-3beta,19-oxide: a diterpene from the aerial parts of Andrographis paniculata. Phytochemistry. 1994;37(5):1477-1479.
Ji LL, Wang Z, Dong F, Zhang WB, Wang ZT. Andrograpanin, a compound isolated from anti-inflammatory traditional Chinese medicine Andrographis paniculata, enhances chemokine SDF-1 alpha-induced leukocytes chemotaxis. J Cell Biochem. 2005;95(5):970-978. doi:10.1002/jcb.2046415937916
Kapil A, Koul IB, Banerjee SK, Gupta BD. Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem Pharmacol. 1993;46(1):182-185. doi:10.1016/0006-2952(93)90364-38347130
Kleipool R. Constituents of Andrographis paniculata Nees. Nature. 1952;169:33-34.
Ko HC, Wei BL, Chiou WF. The effect of medicinal plants used in Chinese folk medicine on RANTES secretion by virus-infected human epithelial cells. J Ethnopharmacol. 2006;107(2):205-210. doi:10.1016/j.jep.2006.03.00416621378
Kumar RA, Sridevi K, Kumar NV, Nanduri S, Rajagopal S. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol. 2004;92(2-3):291-295. doi:10.1016/j.jep.2004.03.00415138014
Kuroyanagi M, Sato M, Ueno A, Nishi K. Flavonoids from Andrographis paniculata. Chem Pharm Bull. 1987;35:4429-4435.
Matsuda T, Kuroyanagi M, Sugiyama S, Umehara K, Ueno A, Nishi K. Cell differentiation-inducing diterpenes from Andrographis paniculata Nees. Chem Pharm Bull (Tokyo). 1994;42(6):1216-1225. doi:10.1248/cpb.42.12168069972
McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Associations Botanical Safety Handbook. CRC Press; 1997.
Medforth C, Chang RS, Chen GQ, Olmstead MM, Smith KM. A conformational study of diterpenoid lactones isolated from the Chinese medicinal herb Andrographis paniculata. J Chem Soc Perkin. 1990:1011-1016.
Mishra SK, Tripathi S, Shukla A, Oh SH, Kim HM. Andrographolide and analogues in cancer prevention. Front Biosci (Elite Ed). 2015;7:255-266. doi:10.2741/E73225553378
Misra P, et al. Antimalarial activity of Andrographis paniculata (Kalmegh) against Plasmodium berghei NK 65 in Mastomys natalensis. Int J Pharmacog. 1992;30(4):263-274.
Mkrtchyan A, Panosyan V, Panossian A, Wikman G, Wagner H. A phase I clinical study of Andrographis paniculata fixed combination Kan Jang versus ginseng and valerian on the semen quality of healthy male subjects. Phytomedicine. 2005;12(6-7):403-409. doi:10.1016/j.phymed.2004.10.00416008115
Najib Nik A Rahman N, Furuta T, Kojima S, Takane K, Ali Mohd M. Antimalarial activity of extracts of Malaysian medicinal plants. J Ethnopharmacol. 1999;64(3):249-254. doi:10.1016/s0378-8741(98)00135-410363840
Nanduri S, Nyavanandi VK, Thunuguntla SS, et al. Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents. Bioorg Med Chem Lett. 2004;14(18):4711-4717. doi:10.1016/j.bmcl.2004.06.09015324893
Ogundola AF, Akhigbe RE, Saka WA, et al. Contraceptive potential of Andrographis paniculata is via androgen suppression and not induction of oxidative stress in male Wistar rats. Tissue Cell. 2021;73:101632. doi:10.1016/j.tice.2021.10163234479074
Otake T, Mori H, Morimoto M, Ueba N, et al. Screening of Indonesian plant extracts for anti-human immunodeficiency virus-type I (HIV-1) activity. Phytother Res. 1995;9:6-10.
Padmesh P, Sabu KK, Seeni S, Pushpangadan P, et al. The use of RAPD in assessing genetic variability in Andrographis paniculata Nees, a hepatoprotective drug. Curr Sci. 1999;76:833-835.
Panche AN, Chandra S, Diwan AD. Multi-target β-protease inhibitors from Andrographis paniculata: in silico and in vitro studies. Plants (Basel). 2019;8(7):231. doi:10.3390/plants807023131319560
Panossian A, Davtyan T, Gukassyan N, et al. Effect of andrographolide and Kan Jang—fixed combination of extract SHA-10 and extract SHE-3—on proliferation of human lymphocytes, production of cytokines and immune activation markers in the whole blood cells culture. Phytomedicine. 2002;9(7):598-605. doi:10.1078/09447110232161640912487323
Panraksa P, Ramphan S, Khongwichit S, Smith DR. Activity of andrographolide against dengue virus. Antiviral Res. 2017;139:69-78. doi:10.1016/j.antiviral.2016.12.01428034742
Phunikhom K, Khampitak K, Aromdee C, Arkaravichien T, Sattayasai J. Effect of Andrographis paniculata extract on triglyceride levels of the patients with hypertriglyceridemia: a randomized controlled trial. J Med Assoc Thai. 2015;98(suppl 6):S41-S47.26434249
Poolsup N, Suthisisang C, Prathanturarug S, Asawamekin A, Chanchareon U. Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials. J Clin Pharm Ther. 2004;29(1):37-45. doi:10.1046/j.1365-2710.2003.00534.x14748896
Puri A, Saxena R, Saxena RP, Saxena KC, Srivastava V, Tandon JS. Immunostimulant agents from Andrographis paniculata. J Nat Prod. 1993;56(7):995-999. doi:10.1021/np50097a0028377022
Rahmi EP, Kumolosasi E, Jalil J, Buang F, Jamal JA. Extracts of Andrographis paniculata (Burm.f.) Nees leaves exert anti-gout effects by lowering uric acid levels and reducing monosodium urate crystal-induced inflammation. Front Pharmacol. 2022;12:787125. doi:10.3389/fphar.2021.78712535095497
Rajani M, Shrivastava N, Ravishankara MN. A rapid method for isolation of andrographolide from Andrographis paniculata Nees (Kalmegh). Pharm Biol. 2000;38(3):204-209. doi:10.1076/1388-0209(200007)3831-SFT20421214463
Rajanna M, Bharathi B, Shivakumar BR, et al. Immunomodulatory effects of Andrographis paniculata extract in healthy adults - an open-label study. J Ayurveda Integr Med. 2021;12(3):529-534. doi:10.1016/j.jaim.2021.06.00434376353
Reddy VL, Reddy SM, Ravikanth V, et al. A new bis-andrographolide ether from Andrographis paniculata Nees and evaluation of anti-HIV activity. Nat Prod Res. 2005;19(3):223-230. doi:10.1080/1478641041000170919715702635
Reyes BA, Bautista ND, Tanquilut NC, et al. Anti-diabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats. J Ethnopharmacol. 2006;105(1-2):196-200. doi:10.1016/j.jep.2005.10.01816298503
Sandborn WJ, Targan SR, Byers VS, et al. Andrographis paniculata extract (HMPL-004) for active ulcerative colitis. Am J Gastroenterol. 2013;108(1):90-98. doi:10.1038/ajg.2012.34023044768
Sa-Ngiamsuntorn K, Suksatu A, Pewkliang Y, et al. Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. J Nat Prod. 2021;84(4):1261-1270. doi:10.1021/acs.jnatprod.0c0132433844528
Sareer O, Ahmad S, Umar S. Andrographis paniculata: a critical appraisal of extraction, isolation and quantification of andrographolide and other active constituents. Nat Prod Res. 2014;28(23):2081-2101. doi:10.1080/14786419.2014.92400424912126
Saxena RC, Singh R, Kumar P, et al. A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection. Phytomedicine. 2010;17(3-4):178-185. doi:10.1016/j.phymed.2009.12.00120092985
Schwyzer R, et al. Uber andrographolid. Helv Chim Acta. 1951;34:652-677.
Shang YX, Shen C, Stub T, et al. Adverse effects of andrographolide derivative medications compared to the safe use of herbal preparations of Andrographis paniculata: results of a systematic review and meta-analysis of clinical studies. Front Pharmacol. 2022;13:773282. doi:10.3389/fphar.2022.77328235153776
Sharma V, Sharma R, Sharma VL. Andrographis paniculata mitigates first-line anti-tubercular drugs-induced nephrotoxicity in Wistar rats. Biomarkers. 2022;27(4):325-337. doi:10.1080/1354750X.2022.204344435196932
Sheeja K, Guruvayoorappan C, Kuttan G. Antiangiogenic activity of Andrographis paniculata extract and andrographide. Int Immunopharmacol. 2007;7(2):211-221. doi:10.1016/j.intimp.2006.10.00217178389
Shen YC, Chen CF, Chiou WF. Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide. Planta Med. 2000;66(4):314-317. doi:10.1055/s-2000-853710865445
Singha PK, Roy S, Dey S. Antimicrobial activity of Andrographis paniculata. Fitoterapia. 2003;74(7-8):692-694. doi:10.1016/s0367-326x(03)00159-x14630176
Siti Najila MJ, Noor Rain A, Mohamad Kamel AG, et al. The screening of extracts from Goniothalamus scortechinii, Aralidium pinnatifidum and Andrographis paniculata for anti-malarial activity using the lactate dehydrogenase assay. J Ethnopharmacol. 2002;82(2-3):239-242. doi:10.1016/s0378-8741(02)00183-612242001
Smith AB, Toder BH, Carroll PJ, et al. Andrographolide: an x-ray crystallographic analysis. J Crystallogr Spectrosc Res. 1982;12(4):309-319.
Smith PL, Maloney KN, Pothen RG, Clardy J, Clapham DE. Bisandrographolide from Andrographis paniculata activates TRPV4 channels. J Biol Chem. 2006;281(40):29897-29904. doi:10.1074/jbc.M60539420016899456
Spasov AA, Ostrovskij OV, Chernikov MV, Wikman G. Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children. Phytother Res. 2004;18(1):47-53. doi:10.1002/ptr.135914750201
Stopponi S, Fotio Y, Cifani C, et al. Andrographis paniculata and its main bioactive ingredient andrographolide decrease alcohol drinking and seeking in rats through activation of nuclear PPARγ pathway. Alcohol Alcohol. 2021;56(2):240-249. doi:10.1093/alcalc/agaa13633401299
Sukkanon C, Karpkird T, Saeung M, et al. Excito-repellency activity of Andrographis paniculata (Lamiales: Acanthaceae) against colonized mosquitoes. J Med Entomol. 2020;57(1):192-203. doi:10.1093/jme/tjz13931550361
Tang T, Targan SR, Li ZS, Xu C, Byers VS, Sandborn WJ. Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther. 2011;33(2):194-202. doi:10.1111/j.1365-2036.2010.04515.x21114791
Tanwettiyanont J, Piriyachananusorn N, Sangsoi L, Boonsong B, et al. Use of Andrographis paniculata (Burm.f.) Wall. ex Nees and risk of pneumonia in hospitalised patients with mild coronavirus disease 2019: a retrospective cohort study. Front Med (Lausanne). 2022;9:947373. doi:10.3389/fmed.2022.94737336035418
Thamlikitkul V, Dechatiwongse T, Theerapong S, et al. Efficacy of Andrographis paniculata, Nees for pharyngotonsillitis in adults. J Med Assoc Thai. 1991;74(10):437-442.1797953
Trivedi N, et al. Hepatoprotective and toxicological evaluation of Andrographis paniculata on severe liver damage. Indian J Pharmacol. 2000;32:288-293.
Visen PK, Shukla B, Patnaik GK, Dhawan BN. Andrographolide protects rat hepatocytes against paracetamol-induced damage. J Ethnopharmacol. 1993;40(2):131-136. doi:10.1016/0378-8741(93)90058-d8133653
Voravuthikunchai SP, Limsuwan S. Medicinal plant extracts as anti-Escherichia coli O157:H7 agents and their effects on bacterial cell aggregation. J Food Prot. 2006;69(10):2336-2341. doi:10.4315/0362-028x-69.10.233617066910
Weiming C, Xiaotian L. Deoxyandrographolide-19beta-D-glucoside from the leaves of Andrographis paniculata. Planta Med. 1982;45(4):245-246. doi:10.1055/s-2007-97138317396922
Yao XJ, Wainberg MA, Parniak MA. Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris. Virology. 1992;187(1):56-62. doi:10.1016/0042-6822(92)90294-y1371029
Zhang CY, Tan BK. Effects of 14-deoxyandrographolide and 14-deoxy-11,12-didehydroandrographolide on nitric oxide production in cultured human endothelial cells. Phytother Res. 1999;13(2):157-159. doi:10.1002/(SICI)1099-1573(199903)13:2<157::AID-PTR388>3.0.CO;2-B10190192
Zhang XF, Tan BK. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats. Acta Pharmacol Sin. 2000;21(12):1157-1164.11603293
Zhou J, Zhang S, Ong CN, Shen HM. Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem Pharmacol. 2006;72(2):132-144. doi:10.1016/j.bcp.2006.04.01916740251

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.